Clinical Trial Update: Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and safety study of ceftobiprole in neonates and infants up to 3 months treated with systemic antibiotics; study terminated with posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infection

Drugs mentioned

• ceftobiprole (ceftobiprole)

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Bacterial Infections | Phase 1 | Status: TERMINATED | Results posted: 2021-01-06